KENYON LAWRENCE A
Chief Financial Officer
- Shares
- 101,010
- Price
- —
- Value
- —
OTLK
4 buyers account for the net balance. There is no cluster of three distinct buyers within 30 days. We found 4 CEO/CFO purchases over 12 months.
Only open-market P purchases and S sales count toward the signal. Vesting, options, taxes and gifts remain in the source data but do not trigger alerts. Rule 10b5-1 trades are shown as informational.
3-month balance
+$2,499,999
4 buyers · 0 sellers
12-month purchases
$7,867,772
8 distinct insiders
12-month sales
$0.00
0 distinct insiders
Highlighted alerts
16
0 Rule 10b5-1 trades treated as informational
Buying cluster · 30 days
Fewer than three distinct buyers
CEO/CFO purchases · 12 months
4 executive purchases found
The same filtered trades as JSON for your scripts, alerts or AI agent, for 5,500+ US companies — plus sentiment, news, financials and breakout setups. Free · every API · 1,000 requests a month · no card required.
OTLK overview: breakout setup, X sentiment and insiders in one page →
The SEC XML stores every transaction. Raspberry keeps that evidence, reads the footnotes and separates voluntary open-market activity from vesting, option exercises, gifts, tax withholding, stock purchase and dividend reinvestment plans and pre-programmed 10b5-1 trades.
The option was granted by Outlook Therapeutics, Inc. (the "Issuer") as an inducement material to the Reporting Person's entry into employment with the Issuer in accordance with Nasdaq Listing Rule 5635(c)(4). 25% of the shares subject to the option shall vest on September 1, 2027, with the remaining shares vesting in equal monthly installments over the following three years thereafter, subject to the Reporting Person's continuous service with the Issuer on each such date.
Voluntary purchases and sales; administrative noise stays hidden.
KENYON LAWRENCE A
Chief Financial Officer
KENYON LAWRENCE A
Chief Financial Officer
Jahr Robert Charles
Chief Executive Officer
Jahr Robert Charles
Chief Executive Officer
Sukhtian Ghiath M.
Director
Sukhtian Ghiath M.
Director
Sukhtian Faisal Ghiath
Director
Haddadin Yezan Munther
Director
Sukhtian Ghiath M.
Director
Sukhtian Ghiath M.
Director
Sukhtian Ghiath M.
Director
Sukhtian Ghiath M.
Director
Sukhtian Faisal Ghiath
Director
Haddadin Yezan Munther
Director
THURMAN RANDY H
Director
HILZINGER KURT J
Director
| Date | Insider | Transaction | Shares | Price | Value | Reading |
|---|---|---|---|---|---|---|
| Aug 14, 2026 | KENYON LAWRENCE A Chief Financial Officer | Purchase | 101,010 | — | — | |
| Aug 14, 2026 | KENYON LAWRENCE A Chief Financial Officer | Purchase | 101,010 | — | — | |
| Aug 14, 2026 | Jahr Robert Charles Chief Executive Officer | Purchase | 151,515 | — | — | |
| Aug 14, 2026 | Jahr Robert Charles Chief Executive Officer | Purchase | 151,515 | — | — | |
| Aug 12, 2026 | Sukhtian Ghiath M. Director | Purchase | 2,525,252 | $0.99 | $2,499,999 | |
| Aug 12, 2026 | Sukhtian Ghiath M. Director | Purchase | 2,525,252 | $0.00 | $0.00 | |
| Jul 29, 2026 | Sukhtian Faisal Ghiath Director | Purchase | 95,398 | $1.05 | $99,996 | |
| Jun 02, 2026 | Haddadin Yezan Munther Director | Purchase | 29,000 | $0.83 | $24,145 | |
| May 28, 2026 | Sukhtian Ghiath M. Director | Purchase | 8,539,709 | $0.59 | $5,000,000 | |
| May 28, 2026 | Sukhtian Ghiath M. Director | Purchase | 8,571,428 | — | — | |
| May 28, 2026 | Sukhtian Ghiath M. Director | Purchase | 3,458,571 | — | — | |
| May 28, 2026 | Sukhtian Ghiath M. Director | Purchase | 3,458,571 | — | — | |
| May 27, 2026 | Sukhtian Faisal Ghiath Director | Purchase | 122,174 | $0.41 | $50,006 | |
| May 26, 2026 | Haddadin Yezan Munther Director | Purchase | 34,000 | $0.44 | $14,960 | |
| May 26, 2026 | THURMAN RANDY H Director | Purchase | 5,000 | $0.43 | $2,145 | |
| May 26, 2026 | HILZINGER KURT J Director | Purchase | 400,000 | $0.44 | $176,520 |
“Alert” means a voluntary, unscheduled transaction according to the filing; it is not an investment recommendation. Official source: SEC EDGAR.